NO991563D0 - N-substituerte azaheterosykliske forbindelser - Google Patents
N-substituerte azaheterosykliske forbindelserInfo
- Publication number
- NO991563D0 NO991563D0 NO991563A NO991563A NO991563D0 NO 991563 D0 NO991563 D0 NO 991563D0 NO 991563 A NO991563 A NO 991563A NO 991563 A NO991563 A NO 991563A NO 991563 D0 NO991563 D0 NO 991563D0
- Authority
- NO
- Norway
- Prior art keywords
- substituted azaheterocyclic
- azaheterocyclic compounds
- compounds
- substituted
- azaheterocyclic
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK108996 | 1996-10-04 | ||
| PCT/DK1997/000421 WO1998015546A1 (en) | 1996-10-04 | 1997-10-02 | N-substituted azaheterocyclic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO991563D0 true NO991563D0 (no) | 1999-03-30 |
| NO991563L NO991563L (no) | 1999-06-03 |
Family
ID=8100875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO991563A NO991563L (no) | 1996-10-04 | 1999-03-30 | N-substituerte, azaheterosykliske forbindelser |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6569849B1 (no) |
| EP (1) | EP0934306A1 (no) |
| JP (1) | JP2001501629A (no) |
| KR (1) | KR20000048909A (no) |
| CN (1) | CN1234797A (no) |
| AU (1) | AU741839B2 (no) |
| BR (1) | BR9712202A (no) |
| CA (1) | CA2267500A1 (no) |
| CZ (1) | CZ114199A3 (no) |
| HU (1) | HUP0000088A3 (no) |
| IL (1) | IL129122A0 (no) |
| NO (1) | NO991563L (no) |
| PL (1) | PL332593A1 (no) |
| WO (1) | WO1998015546A1 (no) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6509346B2 (en) | 1998-01-21 | 2003-01-21 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| AU2335699A (en) * | 1998-01-21 | 1999-08-09 | Kyowa Hakko Kogyo Co. Ltd. | Chemokine receptor antagonists and methods of use therefor |
| US6613905B1 (en) | 1998-01-21 | 2003-09-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| EP1049700B9 (en) | 1998-01-21 | 2006-05-10 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US7271176B2 (en) | 1998-09-04 | 2007-09-18 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use thereof |
| US7355042B2 (en) * | 2001-10-16 | 2008-04-08 | Hypnion, Inc. | Treatment of CNS disorders using CNS target modulators |
| US7541365B2 (en) | 2001-11-21 | 2009-06-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| TW200301698A (en) | 2001-12-21 | 2003-07-16 | Bristol Myers Squibb Co | Acridone inhibitors of IMPDH enzyme |
| TWI291467B (en) | 2002-11-13 | 2007-12-21 | Millennium Pharm Inc | CCR1 antagonists and methods of use therefor |
| WO2004112705A2 (en) * | 2003-06-16 | 2004-12-29 | Hypnion, Inc. | Methods for treating sleep disorders |
| WO2005020913A2 (en) * | 2003-08-25 | 2005-03-10 | Combinatorx, Incorporated | Formulations, conjugates, and combinations of drugs for the treatment of neoplasms |
| RS53277B (sr) * | 2006-06-28 | 2014-08-29 | Amgen Inc. | Inhibitori transportera-1 glicina |
| US8034940B2 (en) | 2006-08-09 | 2011-10-11 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| SE531698C2 (sv) | 2007-07-12 | 2009-07-07 | Respiratorius Ab | Nya bronkdilaterande a,b-omättade amider |
| US20090215643A1 (en) | 2007-07-26 | 2009-08-27 | Cellay, Llc | Highly Visible Chromosome-Specific Probes and Related Methods |
| US9162980B2 (en) | 2009-01-09 | 2015-10-20 | Board Of Regents Of The University Of Texas System | Anti-depression compounds |
| US8362277B2 (en) | 2009-01-09 | 2013-01-29 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
| BRPI1006825A2 (pt) | 2009-01-09 | 2019-04-24 | Univ Texas | compostos pró-neurogênicos |
| US20130203055A1 (en) | 2010-06-03 | 2013-08-08 | Joan Aurich-Costa | Methods and kits for in situ detection of nucleotide sequences |
| JP6126528B2 (ja) | 2010-07-07 | 2017-05-10 | ザ・ボード・オブ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・テキサス・システムＴｈｅ Ｂｏａｒｄ Ｏｆ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｔｅｘａｓ Ｓｙｓｔｅｍ | 神経新生促進化合物 |
| WO2013026455A1 (en) * | 2011-08-24 | 2013-02-28 | Aarhus Universitet | Permanently positively charged antidepressants |
| WO2013090386A2 (en) | 2011-12-12 | 2013-06-20 | Cellay, Inc. | Methods and kits for room temperature in situ detection of a target nucleic acid in a biological sample |
| CA2882826A1 (en) * | 2012-08-24 | 2014-02-27 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
| JP2015536651A (ja) | 2012-10-31 | 2015-12-24 | セレー，インコーポレイテッド | インサイチュハイブリダイゼーションを行うための方法およびキット |
| CA2929932A1 (en) | 2013-11-07 | 2015-05-14 | Cellay, Inc. | Methods and kits for detecting a prostate carcinoma and predicting disease outcomes for prostate cancers |
| WO2015070234A2 (en) | 2013-11-11 | 2015-05-14 | Board Of Regents Of The University Of Texas System | Neuroprotective compounds and use thereof |
| WO2015070237A1 (en) | 2013-11-11 | 2015-05-14 | Board Of Regents Of The University Of Texas System | Neuroprotective chemicals and methods for identifying and using same |
| CN111171006B (zh) * | 2020-01-29 | 2023-05-12 | 成都睿智化学研究有限公司 | 一种3-取代亚氨基二苄氨基类化合物的工艺方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3123610A (en) * | 1964-03-03 | Alkanoylpiperidinoalkyl | ||
| US3058979A (en) * | 1957-05-13 | 1962-10-16 | Smith Kline French Lab | New perfluoroalkylphenothiazine derivatives |
| FR1212031A (fr) * | 1957-10-21 | 1960-03-21 | Rhone Poulenc Sa | Dérivés de la phénothiazine substitués à l'azote par une chaîne basique comportant un hétérocycle et leur préparation |
| BE566958A (no) * | 1958-04-19 | |||
| CH374682A (de) * | 1959-08-28 | 1964-01-31 | Geigy Ag J R | Verfahren zur Herstellung von neuen N-heterocyclischen Verbindungen |
| FR1578748A (no) * | 1967-12-28 | 1969-08-22 | ||
| AT288414B (de) * | 1968-04-20 | 1971-03-10 | Egyt Gyogyszervegyeszeti Gyar | Verfahren zur Herstellung von N-heterocyclischen Verbindungen und ihren Salzen |
| NO127151B (no) * | 1969-03-28 | 1973-05-14 | Ciba Geigy Ag | |
| FR2005201B1 (no) * | 1969-05-20 | 1973-03-16 | Auguil Ste Civile | |
| GB1323659A (en) * | 1971-04-10 | 1973-07-18 | Yoshitomi Pharmaceutical | Piperazine derivatives methods for their production and pharmaceuticl compositions containing them |
| US3828034A (en) * | 1972-05-25 | 1974-08-06 | Syntex Inc | Tricyclic pharmacological agents,intermediates and methods of making |
| FR2186249A1 (en) * | 1972-05-31 | 1974-01-11 | Synthelabo | Phenyl piperazinoalkyl (dihydro)dibenzazepines - antidepressants having low toxicity |
| US3965181A (en) * | 1973-07-06 | 1976-06-22 | Syntex (U.S.A.) Inc. | Tricyclic pharmacological agents, intermediates and methods of making |
| GB1480593A (en) * | 1973-11-30 | 1977-07-20 | Kefalas As | Xanthene and thioxanthene derivatives having pharmaceutical activity |
| DE3444837A1 (de) * | 1984-12-08 | 1986-06-12 | Basf Ag, 6700 Ludwigshafen | 10,11-dihydro-5h-dibenzo(a,d)cycloheptadien- derivate, ihre herstellung und verwendung |
| MY113463A (en) * | 1994-01-04 | 2002-03-30 | Novo Nordisk As | Novel heterocyclic compounds |
| US5716949A (en) * | 1995-04-07 | 1998-02-10 | Novo Nordisk A/S | Heterocyclic compounds |
| DE69720021T2 (de) * | 1996-10-04 | 2004-02-05 | Novo Nordisk A/S | 1,4-disubstituierte piperazine |
| US6040318A (en) * | 1997-06-25 | 2000-03-21 | Novo Nordisk A/S | Tricycle substituted with azaheterocyclic carboxylic acids |
-
1997
- 1997-10-02 CZ CZ991141A patent/CZ114199A3/cs unknown
- 1997-10-02 WO PCT/DK1997/000421 patent/WO1998015546A1/en not_active Ceased
- 1997-10-02 JP JP10517092A patent/JP2001501629A/ja active Pending
- 1997-10-02 HU HU0000088A patent/HUP0000088A3/hu unknown
- 1997-10-02 EP EP97941883A patent/EP0934306A1/en not_active Ceased
- 1997-10-02 CN CN97199183A patent/CN1234797A/zh active Pending
- 1997-10-02 IL IL12912297A patent/IL129122A0/xx unknown
- 1997-10-02 BR BR9712202-5A patent/BR9712202A/pt unknown
- 1997-10-02 AU AU43771/97A patent/AU741839B2/en not_active Ceased
- 1997-10-02 PL PL97332593A patent/PL332593A1/xx unknown
- 1997-10-02 CA CA002267500A patent/CA2267500A1/en not_active Abandoned
- 1997-10-02 KR KR1019990702939A patent/KR20000048909A/ko not_active Withdrawn
- 1997-10-03 US US08/943,856 patent/US6569849B1/en not_active Expired - Fee Related
-
1999
- 1999-03-30 NO NO991563A patent/NO991563L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998015546A1 (en) | 1998-04-16 |
| CN1234797A (zh) | 1999-11-10 |
| NO991563L (no) | 1999-06-03 |
| KR20000048909A (ko) | 2000-07-25 |
| AU741839B2 (en) | 2001-12-13 |
| JP2001501629A (ja) | 2001-02-06 |
| HUP0000088A2 (hu) | 2000-06-28 |
| PL332593A1 (en) | 1999-09-27 |
| IL129122A0 (en) | 2000-02-17 |
| US6569849B1 (en) | 2003-05-27 |
| CZ114199A3 (cs) | 1999-09-15 |
| HUP0000088A3 (en) | 2000-09-28 |
| CA2267500A1 (en) | 1998-04-16 |
| EP0934306A1 (en) | 1999-08-11 |
| AU4377197A (en) | 1998-05-05 |
| BR9712202A (pt) | 1999-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO991563D0 (no) | N-substituerte azaheterosykliske forbindelser | |
| DE69729947T2 (de) | N-substituierte 2-cyanopyrrolidine | |
| DE69927844D1 (de) | N-substituierte 2-cyanopyrrolidine | |
| BR9612465A (pt) | Compostos heterocíclicos | |
| EE200000031A (et) | Uued spiroasabitsüklilised heterotsüklilised ühendid | |
| FI962749L (fi) | Uusia heterosyklisiä yhdisteitä | |
| FI973207A7 (fi) | Heterosyklisiä yhdisteitä | |
| DK0820451T3 (da) | Hidtil ukendte heterocykliske forbindelser | |
| NO991564D0 (no) | N-substituerte azaheterosykliske forbindelser | |
| DE69531522D1 (de) | Heterozyklische Verbindungen | |
| FI961844L (fi) | Fenyyli-indoliyhdisteitä | |
| BR9503042A (pt) | Composto de polialquilpiperidina | |
| DE59811182D1 (de) | Heterocyclische Verbindungen | |
| DE50003014D1 (de) | N-substituierte perhydrodiazine | |
| AU4376997A (en) | N-substituted azaheterocyclic compounds | |
| DK0937040T3 (da) | N-substituerede 2-cyanopyrrolidiner | |
| SE9402122D0 (sv) | Heterocyclic compounds | |
| SE9400968D0 (sv) | Heterocyclic compounds | |
| DK0851865T3 (da) | Hidtil ukendte heterocykliske forbindelser | |
| FIU960481U0 (fi) | Pakkaus joulukuusta varten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |